Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.23 USD | -7.85% | -38.12% | -96.47% |
14/06 | CNS Pharmaceuticals, Inc. announced that it expects to receive $1.3725 million in funding | CI |
10/06 | Sector Update: Health Care Stocks Advance Late Afternoon | MT |
Business Summary
Number of employees: 4
Managers
Managers | Title | Age | Since |
---|---|---|---|
John Climaco
CEO | Chief Executive Officer | 55 | 01/17/01 |
Director of Finance/CFO | 45 | 13/19/13 | |
Sandra Silberman
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/17/01 |
Donald Picker
CTO | Chief Tech/Sci/R&D Officer | 78 | 01/18/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Donald Picker
CTO | Chief Tech/Sci/R&D Officer | 78 | 01/18/01 |
John Climaco
CEO | Chief Executive Officer | 55 | 01/17/01 |
Faith Charles
CHM | Chairman | 62 | 03/23/03 |
Jeffry Keyes
BRD | Director/Board Member | 51 | 25/18/25 |
Bettina Cockroft
BRD | Director/Board Member | 57 | 08/23/08 |
Jerzy Gumulka
BRD | Director/Board Member | 74 | 08/17/08 |
Amy Mahery
BRD | Director/Board Member | 47 | 18/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 237,039 | 216,763 ( 91.45 %) | 0 | 91.45 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-96.47% | 574K | |
+35.59% | 51.07B | |
-8.20% | 38.78B | |
+35.03% | 38.61B | |
-8.98% | 27.32B | |
+11.63% | 26.35B | |
-19.12% | 19.46B | |
+40.45% | 13.58B | |
+30.25% | 12.46B | |
-4.11% | 11.75B |
- Stock Market
- Equities
- CNSP Stock
- Company CNS Pharmaceuticals, Inc.